Liquidia Technologies, Inc. $LQDA Shares Purchased by Adage Capital Partners GP L.L.C.

Key Points

• Adage Capital Partners GP L.L.C. increased its stake in Liquidia Technologies by 446.7%, acquiring an additional 376,872 shares, bringing its total ownership to approximately 0.54% of the company, valued at $6.8 million.
• Other institutional investors, including Janus Henderson Group PLC and Tang Capital Management LLC, also significantly boosted their holdings in Liquidia Technologies, indicating strong interest in the stock.
• Liquidia reported a quarterly revenue increase of 141.5%, reaching $8.84 million, despite a loss per share of ($0.49), which missed analyst expectations.

Adage Capital Partners GP L.L.C. boosted its position in Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report) by 446.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 461,248 shares of the company's stock after purchasing an additional 376,872 shares during the quarter. Adage Capital Partners GP L.L.C. owned about 0.54% of Liquidia Technologies worth $6,803,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in LQDA. GAMMA Investing LLC grew its holdings in shares of Liquidia Technologies by 65.6% during the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock worth $44,000 after buying an additional 1,173 shares in the last quarter. Cetera Investment Advisers boosted its stake in Liquidia Technologies by 4.3% during the fourth quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock worth $367,000 after buying an additional 1,277 shares during the last quarter. Valmark Advisers Inc. boosted its stake in Liquidia Technologies by 7.4% during the first quarter. Valmark Advisers Inc. now owns 18,641 shares of the company's stock worth $275,000 after buying an additional 1,283 shares during the last quarter. Bleakley Financial Group LLC grew its holdings in Liquidia Technologies by 6.4% in the 1st quarter. Bleakley Financial Group LLC now owns 25,308 shares of the company's stock valued at $373,000 after buying an additional 1,523 shares in the last quarter. Finally, Significant Wealth Partners LLC increased its stake in shares of Liquidia Technologies by 14.1% in the 1st quarter. Significant Wealth Partners LLC now owns 14,396 shares of the company's stock worth $212,000 after acquiring an additional 1,780 shares during the last quarter. Hedge funds and other institutional investors own 64.54% of the company's stock.

Wall Street Analysts Forecast Growth

LQDA has been the topic of a number of analyst reports. Oppenheimer set a $13.00 target price on shares of Liquidia Technologies and gave the stock an "underperform" rating in a research note on Monday, May 19th. BTIG Research reaffirmed a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Bank of America decreased their price objective on Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating on the stock in a report on Wednesday, June 11th. Wall Street Zen upgraded Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Finally, HC Wainwright lifted their price target on shares of Liquidia Technologies from $29.00 to $35.00 and gave the company a "buy" rating in a research report on Wednesday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $32.11.

Insider Buying and Selling at Liquidia Technologies

In related news, insider Rajeev Saggar sold 20,000 shares of the company's stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $27.85, for a total transaction of $557,000.00. Following the sale, the insider directly owned 249,727 shares in the company, valued at approximately $6,954,896.95. This represents a 7.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Paul B. Manning sold 328,268 shares of Liquidia Technologies stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $28.78, for a total transaction of $9,447,553.04. Following the completion of the transaction, the director owned 430,828 shares of the company's stock, valued at $12,399,229.84. This represents a 43.24% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 835,573 shares of company stock valued at $22,514,890. 26.50% of the stock is currently owned by company insiders.

Liquidia Technologies Stock Down 3.7%

Shares of NASDAQ LQDA traded down $1.01 during midday trading on Friday, hitting $25.99. The company's stock had a trading volume of 2,211,425 shares, compared to its average volume of 2,193,365. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The firm has a market capitalization of $2.24 billion, a price-to-earnings ratio of -15.29 and a beta of 0.22. The business's fifty day simple moving average is $21.93 and its two-hundred day simple moving average is $17.17. Liquidia Technologies, Inc. has a 1 year low of $9.68 and a 1 year high of $29.94.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative return on equity of 232.96% and a negative net margin of 732.17%.The business had revenue of $8.84 million for the quarter, compared to analyst estimates of $3.90 million. The company's revenue was up 141.5% on a year-over-year basis. On average, equities analysts predict that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Liquidia Technologies Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).